Diabetes Mellitus, Type 2: all 9,590 studies
Page 22 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.
- Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes MellitusCompletedNCT02098733Results posted
- A Study to Evaluate BMS-986036 in Obese Adults With Type-2 DiabetesCompletedNCT02097277Phase 2Results posted
- Impact of Structured Physical Activity Education Delivery in Patients With Type 2 Diabetes MellitusCompletedNCT02093702Not applicableResults posted
- Changing the Healthcare Delivery ModelCompletedNCT02093234Not applicableResults posted
- A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes MellitusCompletedNCT02091362Phase 2Results posted
- Technology Intensified Diabetes Education Study in African AmericansCompletedNCT02088658Not applicableResults posted
- An Evaluation of a Novel Glucose Sensing Technology in Type 2 DiabetesCompletedNCT02082184Not applicableResults posted
- Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT02081599Phase 4Results posted
- mHealth Skill Enhancement Plus Phone CBT for Type 2 Diabetes Distress Medication Nonadherence: Pilot StudyCompletedNCT02081586Not applicableResults posted
- Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot StudyCompletedNCT02081573Not applicableResults posted
- A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-RCompletedNCT02079805Phase 4Results posted
- A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)TerminatedNCT02072096Phase 4Results posted
- Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Insulin Products / Long-term Treatment"CompletedNCT02068508Results posted
- Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise TherapyCompletedNCT02068443Phase 3Results posted
- Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic NephropathyCompletedNCT02065791Phase 3Results posted
- The Safety and Efficacy of MK-1293 Versus Lantus™ in Participants With Type 2 Diabetes Mellitus (MK-1293-006)CompletedNCT02059187Phase 3Results posted
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 DiabetesCompletedNCT02058160Phase 3Results posted
- Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DMCompletedNCT02058147Phase 3Results posted
- A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002)CompletedNCT02055547Phase 1Results posted
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 DiabetesCompletedNCT02054897Phase 3Results posted
- Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 DiabetesCompletedNCT02049814Phase 4Results posted
- Use of Sitagliptin to Decrease MicroalbuminuriaTerminatedNCT02048904Phase 4Results posted
- Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes MellitusCompletedNCT02046395Phase 4Results posted
- Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)CompletedNCT02036515Phase 3Results posted
- A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).CompletedNCT02033889Phase 3Results posted
- Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on MetforminCompletedNCT02033876Phase 2Results posted
- Three Approaches to Glucose Monitoring in Non-insulin Treated DiabetesCompletedNCT02033499Not applicableResults posted
- A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 DiabetesCompletedNCT02030600Phase 3Results posted
- Glycemia in Diabetic Elders TrialTerminatedNCT02029846Phase 4Results posted
- Metabolic Effects of HydroxychloroquineTerminatedNCT02026232Not applicableResults posted
- A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and SitagliptinCompletedNCT02025907Phase 4Results posted
- Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes MellitusCompletedNCT02024971Results posted
- Effect of Saxagliptin on EPCs as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early T2DM PatientsCompletedNCT02024477Phase 4Results posted
- A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 DiabetesTerminatedNCT02020616Phase 1/2Results posted
- A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk FactorsCompletedNCT02019264Phase 4Results posted
- Januvia (Sitagliptin) in Healing Chronic Diabetic Foot UlcersTerminatedNCT02015910Phase 4Results posted
- Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 DiabetesCompletedNCT02014740Phase 4Results posted
- Mood and Diabetes Empowerment & Improvement TrainingCompletedNCT02010684Not applicableResults posted
- Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and AlbuminuriaCompletedNCT02010242Phase 2Results posted
- Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic PatientsCompletedNCT02008942Phase 3Results posted
- The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 DiabetesCompletedNCT02008682Phase 4Results posted
- A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005)CompletedNCT02004886Phase 2Results posted
- Linagliptin Inpatient TrialCompletedNCT02004366Phase 4Results posted
- Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment"CompletedNCT02003014Results posted
- Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"CompletedNCT02002975Results posted
- Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM PatientsCompletedNCT02002221Phase 4Results posted
- Morbidity in Newly Diagnosed type2 Diabetes in AdultsCompletedNCT02002091Results posted
- Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)CompletedNCT01999218Phase 3Results posted
- Use of iPro™2 in Real Life Diabetes Management of Type 2 Patients in IndiaCompletedNCT01995539Not applicableResults posted
- A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusCompletedNCT01991795Phase 3Results posted
- Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.CompletedNCT01991197Phase 2Results posted
- Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes MellitusCompletedNCT01990300Results posted
- A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes MellitusCompletedNCT01989754Phase 4Results posted
- Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004)CompletedNCT01986881Phase 3Results posted
- A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)CompletedNCT01986855Phase 3Results posted
- Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)CompletedNCT01982630Phase 1Results posted
- Fasiglifam 25 mg BID vs 50 mg QDTerminatedNCT01982253Phase 2Results posted
- Hypoglycemia (Low Blood Sugar) and the HeartCompletedNCT01980914Not applicableResults posted
- The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 DiabetesCompletedNCT01980524Phase 2/3Results posted
- Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic PatientsCompletedNCT01975935Phase 2Results posted
- Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 DiabetesCompletedNCT01973231Phase 4Results posted
- Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral TherapyCompletedNCT01972724Phase 4Results posted
- Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003)CompletedNCT01971554Phase 1Results posted
- Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac SurgeryTerminatedNCT01970462Phase 4Results posted
- The Effect of Linagliptin on Mitochondrial and Endothelial FunctionCompletedNCT01969084Phase 4Results posted
- The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE StudyCompletedNCT01966978Phase 4Results posted
- Screening, Brief Intervention, and Referral to Treatment in Primary CareCompletedNCT01966432Not applicableResults posted
- Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With BiguanidesCompletedNCT01964976Results posted
- Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes MellitusCompletedNCT01964963Results posted
- Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With SulfonylureaCompletedNCT01964950Results posted
- A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular EventsCompletedNCT01959529Phase 3Results posted
- A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)CompletedNCT01958671Phase 3Results posted
- SMBG Protocols Predicting Glucose Levels in Senior Diabetes Mellitus With CADCompletedNCT01954771Not applicableResults posted
- A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes MellitusCompletedNCT01952145Phase 3Results posted
- Effect of Exenatide on Liver and Heart Fat and InflammationCompletedNCT01951651Phase 4Results posted
- Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 DiabetesCompletedNCT01951339Not applicableResults posted
- Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)CompletedNCT01948986Phase 1Results posted
- Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT01947855Phase 3Results posted
- Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"CompletedNCT01945242Results posted
- Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"CompletedNCT01945216Results posted
- Vitamin D and Type 2 Diabetes StudyCompletedNCT01942694Not applicableResults posted
- Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive AgentsCompletedNCT01939496Phase 4Results posted
- Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2DCompletedNCT01937598Phase 3Results posted
- Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 DiabetesCompletedNCT01933672Phase 1Results posted
- Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 DiabetesCompletedNCT01930188Phase 3Results posted
- Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking MetforminCompletedNCT01929863Phase 2Results posted
- Initial Clinical Evaluation of an Endoscopic Therapy for Type 2 DiabetesCompletedNCT01927562Not applicableResults posted
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 TabletsCompletedNCT01924767Phase 1Results posted
- Multiple Dose Study Of PF-05231023 In Obese Adult SubjectsTerminatedNCT01923389Phase 1Results posted
- Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 DiabetesCompletedNCT01923181Phase 2Results posted
- Sensor Augmented Pump Therapy Versus Multiple Daily Injection TherapyCompletedNCT01921322Not applicableResults posted
- Liraglutide Hospital Discharge TrialCompletedNCT01919489Phase 4Results posted
- Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 DiabetesCompletedNCT01917656Phase 4Results posted
- Effect of LIK066 on Glucose Absorption in Patients With Type 2 Diabetes MellitusCompletedNCT01915849Phase 1/2Results posted
- Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic PatientsTerminatedNCT01910441Phase 4Results posted
- Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and MetforminCompletedNCT01907854Phase 4Results posted
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal ImpairmentCompletedNCT01907113Phase 1Results posted
- PMS of Trazenta on the Long-term Use as Add-on TherapyCompletedNCT01904383Results posted
- A Regulatory Requirement Non Interventional Study to Monitor Safety and Effectiveness of Trajenta Duo in Type 2 Diabetes Patients in KoreaCompletedNCT01903356Results posted
- Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)CompletedNCT01897532Phase 4Results posted